(Press-News.org) Background
While dual antiplatelet therapy (DAPT) has long been the standard of care for the management of acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI), there is an increasing awareness of the need to find a more patient-centred approach that strikes a balance between the ischaemic protection DAPT offers and the risk of bleeding complications it can create.
The effect of DAPT in dosage and duration on cardiovascular events and bleeding after implantation of drug-coated stents (DCS) in ACS patients, the 4D-ACS trial1, is a Korean trial in which 656 East Asian ACS patients were randomised 1:1 to either a 1-month DAPT with aspirin 100 mg and prasugrel 10 mg (patients ≥75 years or body weight <60 kg received 5 mg of prasugrel) followed by prasugrel 5 mg monotherapy (1M-DAPT) regimen or a 12-month DAPT protocol with aspirin and prasugrel 5 mg (12M-DAPT).
While earlier trials also addressed the issue of DAPT reduction or de-escalation regimes, the 4D-ACS trial is one of the first to randomise patients immediately post-PCI to compare two DAPT protocols, short and long.
The primary endpoint was 12-month net adverse clinical events (NACE), defined as a composite of death, non-fatal myocardial infarction, stroke, ischaemia-driven target vessel revascularisation, and Bleeding Academic Research Consortium (BARC) type 2-5 bleeding.
Results
At 12-months, NACE occurred in 4.9% of the 1M-DAPT group and 8.8% of the 12M-DAPT group meeting criteria for both non-inferiority and superiority.
Major bleeding occurred in 0.6% vs 4.6% (HR 0.13; p=0.007) in the 1M-DAPT vs 12M-DAPT group, respectively.
Ischaemic outcomes were similar in both groups.
Key learnings
While long-term DAPT has been shown to provide early ischaemic benefits reducing life-threatening events such as stent thrombosis, bleeding complications emerging over the long-term maintenance phase can result in clinically significant events associated with increased levels of mortality. Thus, the possibility of having proven de-escalation strategies for DAPT, especially for populations at high risk for bleeding, is a critical addition to available management choices for these patients.
GLOBAL LEADERS, TICO and TWILIGHT, focused on dropping aspirin and continuing P2Y12 inhibitor monotherapy; others, like HOST-REDUCE-POLYTECH RCT and TALOS-AMI, chose to reduce the dose of the P2Y12 inhibitor itself, while TOPIC and TROPICAL-ACS evaluated switching from potent agents to clopidogrel2.
The results of the 4D-ACS trial – one-month DAPT followed by prasugrel 5 mg monotherapy in ACS patients who received a DCS – showed a reduction in NACE by 49%, driven in large part by a 77% reduction in bleeding events compared to the 12-month DAPT regime using the same DCS, demonstrating that this type of de-escalation protocol and DCS implantation enhanced safety and reduced bleeding without compromising ischaemic protection for these ACS patients.
Choice of device
All patients underwent PCI with a biolimus-coated drug-eluting stent, the BioFreedomTM Ultra (Biosensors).
Conclusions and PCR recommendations
The 4C-ACS trial demonstrated the safety and feasibility in East Asian ACS patients of a 1-month DAPT de-escalation protocol with DCS implantation that offered enhanced safety and reducing bleeding without compromising ischaemic protection for these patients.
The trial has certain limitations which prevents its conclusions from being applied to the general population of patients undergoing PCI: only one type of stent platform was used; the de-escalation was unguided and the same for all patients in the short-term DAPT arm; the study population was ethnically similar and further trials would need to study the same approach in a more diverse patient population. Still, the results open the door to an attractive option for patients at increased bleeding risk.
Supporting the viability of a shorter DAPT course followed by low-dose prasugrel monotherapy which can minimise bleeding without compromising ischaemic safety offers the physician a viable option for managing their patients. The 4C-ACS trial is another welcome step in the transition from a “rigid, uniform approach” to DAPT to a “risk-adapted, dynamic and patient-centred model of care”.3
References
Jang Y, Park S-D, Lee JP, et al. One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial. EuroIntervention. 2025. In press. DOI: 10.4244/EIJ-D-25-00331
Capodanno D, Mehran R, Krucoff MW, et al. Defining strategies of modulation of antiplatelet therapy in patients with coronary artery disease: a consensus document from the Academic Research Consortium. Circulation. 2023;147:1933-44. doi: 10.1161/CIRCULATIONAHA.123.064473. Epub 2023 Jun 19.
Cuisset, T, Cayla G. DAPT de-escalation post-ACS: a new rule or just a new option? Lessons from the 4D-ACS trial. EuroIntervention. 2025 In press. Doi: 10.4244/EIJ-E-25-00023
NOTES TO EDITORS
Key information
Session: Hotline /Late-Breaking Trials: Major Late-Breaking Trials from EuroPCR 2025
Presentation: One-month DAPT followed by dose reduction of prasugrel after drug-coated stent insertion in Acute Coronary Syndrome
Presenter: Woong Chol Kang
Palais des Congrès Porte Maillot – Paris, France
21/05 11:15-12:15 Theatre Bleu END
EuroPCR 2025 – One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
2025-05-21
ELSE PRESS RELEASES FROM THIS DATE:
PREVENT equation accurately estimated 10-year CVD risk and those with calcium buildup
2025-05-21
Research Highlights:
The American Heart Association’s PREVENTTM risk calculator accurately identified participants who had calcium buildup in their heart arteries and those who had a higher future heart attack risk, in an analysis of about 7,000 adults in New York City referred for heart disease screening.
The PREVENT scores also predicted future heart attack risk.
Embargoed until 4 a.m. CT/5 a.m. ET Wednesday, May 21, 2025
DALLAS, May 21, 2025 — The PREVENTTM risk calculator helped to identify people with plaque buildup in the arteries of the heart, in addition to predicting their risk of a future heart attack, according ...
Nano-engineered thermoelectrics enable scalable, compressor-free cooling
2025-05-21
Researchers at the Johns Hopkins Applied Physics Laboratory (APL) in Laurel, Maryland, have developed a new, easily manufacturable solid-state thermoelectric refrigeration technology with nano-engineered materials that is twice as efficient as devices made with commercially available bulk thermoelectric materials. As global demand grows for more energy-efficient, reliable and compact cooling solutions, this advancement offers a scalable alternative to traditional compressor-based refrigeration.
In a paper published in ...
Researchers identify a dual origin of cells controlling puberty and reproduction
2025-05-21
Researchers at the Francis Crick Institute have shown that gonadotrophs, cells in the pituitary gland with a key role in puberty and reproduction, come from two different populations, with the majority produced after birth rather than in the embryo, as previously thought.
A better understanding of when these important cells develop could help researchers and clinicians understand and treat disorders that impact puberty and fertility.
In the pituitary, a small gland located in the middle of the head and connected to the brain, gonadotrophs ...
Major step for flat and adjustable optics
2025-05-21
By carefully placing nanostructures on a flat surface, researchers at Linköping University, Sweden, have significantly improved the performance of so-called optical metasurfaces in conductive plastics. This is a major step for controllable flat optics, with future applications such as video holograms, invisibility materials, and sensors, as well as in biomedical imaging. The study has been published in the journal Nature Communications.
To control light, curved lenses are used today, that are often made of glass that is either concave or convex, ...
Less frequent stroke monitoring is safe, effective, and frees up resources, study finds
2025-05-21
Halving the number of times vital signs and neurological function are checked in low-risk patients after treatment for acute ischaemic stroke does not compromise care or recovery, according to new findings presented at the 11th European Stroke Organisation Conference in Helsinki, Finland.
Results from the Optimal Post rTpa-Iv Monitoring in Ischaemic Stroke Trial (OPTIMISTmain)1, simultaneously published in The Lancet, also showed that this approach also had flow-on benefits for nursing workflow and intensive care resources. The trial was led by Professor Craig Anderson from The George Institute for Global Health and UNSW ...
Living tattoos for buildings
2025-05-21
External walls of buildings are normally lifeless and have no additional function. An international team of researchers and companies, in which Carole Planchette from the Institute of Fluid Mechanics and Heat Transfer is involved, wants to change this by adding microbial life to building façades. In the project “Archibiome tattoo for resistant, responsive, and resilient cities” (REMEDY), the consortium is working on integrating specifically composed communities of beneficial microorganisms into ...
Could strawberry tree extract prevent and treat gastrointestinal disorders?
2025-05-21
New research in rats indicates that a Mediterranean plant may be an effective treatment for ulcerative colitis, a type of inflammatory bowel disease. The findings are published in the Journal of the Science of Food and Agriculture.
Various antioxidant and anti-inflammatory medications are used to treat ulcerative colitis, but they can cause numerous side effects. To test the potential of the Arbutus unedo plant (often referred to as the strawberry tree) that is native to the Mediterranean region, investigators gave rats doses of an extract from the plant ...
Can engaging in social activities prolong life?
2025-05-21
A study in the Journal of the American Geriatrics Society indicates that social engagement may help older individuals live longer.
In the study of 2,268 U.S. individuals aged 60 years and older who completed the Psychosocial and Lifestyle Questionnaires and provided blood samples in 2016, there was a strong association between engaging in social activities and a low risk of 4-year mortality. High social engagement was associated with a 42% lower mortality risk than low engagement.
Specific activities, such as charity work, engaging with grandchildren, and participation in sports or social clubs, were particularly significant predictors of a reduced risk ...
Has marijuana legalization affected traditional drug prescriptions?
2025-05-21
Approval of recreational and medical cannabis laws in most U.S. states has allowed individuals to legally obtain cannabis to treat certain medical ailments that had typically been treated with prescription drugs. New research in Health Economics reveals the impact that cannabis laws have had on such traditional prescriptions.
After analyzing prescription drug claims reported by small and large group insurers from 2010–2019 for working-age individuals, investigators found significant reductions in prescription drug claims per enrollee ...
Scientists’ study of white-tailed deer could help control chronic wasting disease
2025-05-21
New research in Wildlife Monographs provides extensive details into the movement of white-tailed deer, with implications for deer management across North America.
For the study, investigators evaluated seasonal activity patterns, home ranges, and habitat selection for nearly 600 white-tailed deer in southwest Wisconsin, USA. The research revealed how an individual deer’s movement and use of space can affect chronic wasting disease transmission.
Chronic wasting disease—a deadly neurological prion ...